Thursday, April 5, 2018

Don’t keep your patients waiting




Long waiting time influences patient satisfaction and physician ratings, according to findings from the 9th Annual Vitals Wait Time Report (https://www.vitals.com/about/posts/press-center/press-releases/9th-annual-vitals-wait-time-report-released).

·         84% patients considered waiting time to be “somewhat important” or “very important” part of the overall experience at the clinic.
·         30% patients walked out due to the long waiting time. The long delays also prompted patients to change their doctor; one in five patients reported changing their doctor as a result.
·         Doctors with the longest average wait time (34 minutes, 11 seconds) were rated lowest (one-star), while physicians with an average wait time of 13 minutes, 17 seconds were given a five-star rating.

This survey is a western study, where punctuality is given great importance, unlike in India, where people generally have a rather lax attitude towards punctuality.

But, punctuality is very important and no patient should be kept waiting, especially in an emergency. Regulation 3.3 of MCI Code of Ethics says, “Utmost punctuality should be observed by a physician in making themselves available for consultations”. A long waiting time negatively affects patient satisfaction.

Almost every patient carries a smartphone today and most patients now do not shy away from expressing their opinion about the quality of services on social media.

A satisfied patient is your best ‘advertisement’. A patient who is satisfied with the care received at your establishment will recommend you to 10 other potential patients, while an unsatisfied patient will talk against you to 100 people.

Punctuality denotes professionalism; it’s a trait worth having and adds value to your ‘brand’.



Dr KK Aggarwal
Padma Shri Awardee
Vice President CMAAO
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of India
Immediate Past National President IMA
                                                     

Wednesday, April 4, 2018

Parasympathetic yoga postures help in prostate cancer



Yoga can reduce the emotional and physical fatigue brought on by cancer treatment. In 2017, scientists reported for the first time that this is also true specifically for men undergoing treatment for prostate cancer.

Men who took a yoga class twice a week during prostate cancer radiation treatment reported less fatigue, fewer sexual side effects, and better urinary functioning than men who did not.

The research team enrolled 50 men aged 53 to 85 years, who were diagnosed with early or advanced nonmetastatic prostate cancer. Of them, 22 were assigned to yoga classes and the rest did not participate in yoga. All the men received scheduled radiation treatments; 29 of them were also on hormonal therapy, and 19 had been treated previously with surgery. The yoga and control groups were evenly balanced with respect to various cancer treatments as well as treatments for side effects.

The yoga sessions (Eischens yoga) lasted 75 minutes each. Before, during, and after the nine-week study, men were asked to rate their fatigue, as well as sexual and urinary symptoms.

Men in the yoga group reported improving or stabilizing symptom scores over time, whereas men in the non-yoga group reported worsening symptoms. According to the study authors, yoga improves erectile and urinary function by strengthening core muscles and improving blood flow. They urged men to keep an open mind and to look for a yoga group and instructor with whom they feel comfortable.

Eischens yoga addresses imbalances and weakness resulting from injuries or habits by improving alignments and muscle stimulation or relaxation. With its emphasis on self-awareness and self-healing, students experience a transformation that is helpful to create more energetic poses and better alignments.

The yogic "locks" of the body are not asanas, per se, they are binds or muscle contractions that make poses more effective and enhance your control of energy. Mula bandha is the root lock, in which you engage the muscles of your pelvic floor.

Dr KK Aggarwal
Padma Shri Awardee
Vice President CMAAO
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of India
Immediate Past National President IMA

Tuesday, April 3, 2018

Areca nut is harmful to human health



Union Minister of State for Skill Development and Entrepreneurship Anant Kumar Hegde said that a delegation would meet Union Health Minister JP Nadda on April 4 and submit him documents that support medicinal properties of areca nut (The Hindu, March 31, 2018).

Heart Care Foundation of India however says that evidence has shown an association between chewing areca nut or betel quid (areca nuts wrapped in betel leaves) and many cancers and a message should not be given to the public that areca nut is a medicine.

There is adequate evidence in published literature to show the harmful effects of areca nuts on health.

·         Chewing of areca nuts or betel quid (areca nuts wrapped in betel leaves), which is widespread in certain regions of Asia, has been implicated in the development of esophageal squamous-cell carcinoma (Eur J Cancer. 2012;48(5):655; West J Med. 1994;160(4):326).
·         Areca nut has a role in pathogenesis of oral submucous fibrosis. The mechanism may involve the release of copper, with resulting induction of collagen synthesis by fibroblasts (Lancet. 1997;349(9063):1447).
·         Betel nut chewing, which is widespread in certain regions of Asia, is an independent risk factor for the development of oral/oropharyngeal cancer (Int J Cancer. 2014;135(6):1433). 
·         Case control trials have suggested that Betel nut chewing, which is widespread in certain regions of Asia, may be an independent risk factor for the development of cirrhosis and hepatic cell carcinoma (Br J Cancer. 2001;84:709; Medicine (Baltimore). 2003;82:365;Medicine (Baltimore). 2004;83:176).
·         Betel quid chewing, a common practice in Southeast Asia, has also been associated with calcium oxalate and calcium phosphate kidney stones (Urol Res. 2006;34:239).


Messages such as this create a misconception in the public and encourage them to use something, which has been proven to be harmful to human health.

Monday, April 2, 2018

Maintain the dignity and honor of patient at all times




Respect for others is inherent in our Indian culture. This is what we teach our children, to always respect other human beings and importantly, to be respectful towards every living being.

Doctors have an ethical duty to uphold the dignity and honor of the medical profession (Regulation 1.1.1 MCI Code of Ethics). Patients are our assets. A healthcare establishment cannot serve its purpose without patients; nor can doctors. The human body, both living and the dead body, has to be respected all times.

Recently, a video of an amputated foot being used as a pillow for a patient in Jhansi went viral. And, as recent as Saturday, a video of a patient supposedly in the emergency ward in JN Medical College and Hospital in Aligarh, with his hands and legs tied on a bed with no side railings, was probably seen by hundreds of people.

Such instances are indicative of the ‘apathy’ that has become so pervasive in almost all walks of life.

But we are different. Doctors cannot disrespect the patient, nor can they be rude to the patient. Anybody else can, but not doctors.

The dignity and honor of the patient needs to be maintained at all times. “God is watching you” this fear of a punishment from the Almighty acted as a deterrent earlier, but not now.

This is the age of the smartphone and the camera in the phone has its eye on you all the time; Google and Facebook are now “God” and any video can be made viral at any instant of time.

Etiquettes and respect need to come back in our day to day interactions with not only our patients, but also with others. “Patience and delicacy should characterize the physician”, says MCI Regulation 2.2.

Patients are our first and foremost concern and their health and well-being is our responsibility and also a priority. An apathetic attitude needs to be shed off; it cannot be a routine for us.

This attitude speaks volumes about lack of attention to detailing and acceptance of mediocrity in place of excellence. Patients now are not generally accepting of any mishap that may occur during the course of treatment.

No excuse will work now - being stressed or overworked, lack of resources and infrastructure, insufficient staff etc.

Few months back, I had written, “if nothing goes wrong then "chalta hai", but if something goes wrong then this “chalta hai” becomes “chalta nahi hai”. So change your attitude from "Kya pharak padta hai" to "bahut pharak padta hai".

It’s important to reiterate these lines as their significance has become all the more relevant today.


Dr KK Aggarwal
Padma Shri Awardee
Vice President CMAAO
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of India
Immediate Past National President IMA

Sunday, April 1, 2018

Informed and documented consent is a must before any off-label use of a drug

Dr KK Aggarwal
Padma Shri Awardee

Off-label use of drugs is a common practice all over the world. Off label use means that the particular drug is used for an indication that is not otherwise approved by the regulatory authority, the Drug Controller General of India (DCGI) in our country, and is not included in the package insert. The package insert or label carries instructions about indications, contraindications and dosing and other instructions. This information is approved by the DCGI for every drug sold in India.
In the Anuradha Saha case of medical negligence, the dose of the injection depomedrol prescribed (80 mg twice daily) was much higher than the maximum recommended dose as recommended by the manufacturer. Anything, which is not as recommended by the manufacturers or is outside DCGI’s recommendations is off-label use and can be called a trial.
Informed and documented consent must be taken from the patient and/or relatives before any off-label use of a drug. And, this ‘documented’ consent must be preserved.
The NICE guidelines on the diagnosis and management of constipation in children and young people also emphasize that PEG is not approved for use to treat chronic constipation in children younger than two years. And, before using it in this age group, informed consent should be taken, which must be documented.
Table 4 Laxatives: recommended doses
LaxativesRecommended doses
Macrogols
Polyethylene glycol 3350 + electrolytes
Paediatric formula: oral powder: macrogol 3350 (polyethylene glycol 3350)a 6.563 g; sodium bicarbonate 89.3 mg; sodium chloride 175.4 mg; potassium chloride 25.1 mg/sachet. 
Disimpaction
  1.  Child under 1 year: ½ to 1 sachet daily (non-BNFC recommended dose)
  2. Child 1–5 years: 2 sachets on 1st day, then 4 sachets daily for 2 days, then 6 sachets daily for 2 days, then 8 sachets daily (non-BNFC recommended dose)
  3. Child 5–12 years: 4 sachets on 1st day, then increased in steps of 2 sachets daily to maximum of 12 sachets daily (Non-BNFC recommended schedule)
Ongoing maintenance (chronic constipation, prevention of faecal impaction)
  1.  Child under 1 year: ½ to 1 sachet daily (non-BNFC recommended dose)
  2. Child 1–6 years: 1 sachet daily; adjust dose to produce regular soft stools (maximum 4 sachets daily) (for children under 2, non-BNFC dose)
  3. Child 6–12 years: 2 sachets daily; adjust dose to produce regular soft stools (maximum 4 sachets daily)
  1. Unless stated otherwise, doses are those recommended by the British National Formulary for Children (BNFC) 2009. Informed consent should be obtained and documented whenever medications/doses are prescribed that are different from those recommended by the BNFC.At the time of publication (May 2010) Movicol Paediatric Plain is the only macrogol licensed for children under 12 years that includes electrolytes. It does not have UK marketing authorisation for use in faecal impaction in children under 5 years, or for chronic constipation in children under 2 years. Informed consent should be obtained and documented. Movicol Paediatric Plain is the only macrogol licensed for children under 12 years that is also unflavoured.
Knowledge is our best defense. Forearmed is better prepared…Unfortunately, these important subjects of CDSCO and DCGI are not taught in Pharmacology.
It is time that we begin to read about the DCGI drug approval procedure in the country. Because if we do not, then patients might start challenging us.

Saturday, March 31, 2018

More children being diagnosed with Type 1 diabetes in India

More children being diagnosed with Type 1 diabetes in India
With certain precautions, it is possible for kids with this condition to lead a normal life
New Delhi, 30th March 2018: The incidence of Type 1 diabetes is on the rise among children today with about 97,000 of them affected in India alone. About 32 per lakh children are affected in Delhi alone. Type 1 diabetes is also called juvenile diabetes as it affects children primarily.
Type 1 diabetes is caused when the immunity of a person turns against the body killing insulin-producing cells in the pancreas. Life can be traumatic for children with this condition as they need to regularly take insulin injections, which can become a reason for their stigmatization.
Speaking about this, Padma Shri Awardee Dr K K Aggarwal, President Heart Care Foundation of India (HCFI) and Immediate Past National President Indian Medical Association (IMA),said, “There are many myths surrounding Type 1 diabetes which can hinder effective treatment. For instance, there is lack of awareness about better ways to track and manage glucose levels, such as that by a Glucometer or insulin pumps. It is imperative to educate the society that children with this condition can lead very normal lives and be as active as others. Type 1 diabetes is not caused due to high intake of sugar. Although diet, activity level, and weight have not been found as a causative factor for the onset of Type 1 diabetes, it is always better to exercise and eat a balanced diet as precaution. Parents have a large role to play in leading by example.”
Some symptoms of Type 1 diabetes include excessive thirst, frequent urination, hunger and tiredness, weight loss, slow-healing sores, dry and itchy skin, tingling sensation in the feet, and blurry eyesight.
Adding further, Dr Aggarwal who is also the Vice President of CMAAO, said, “Type-1 diabetes cannot be cured. Insulin helps to control blood sugar levels and is key to lifelong management of this condition, along with regular blood sugar monitoring. It is important for parents to teach and help their children take their insulin and educate teachers and caregivers about it too, especially when children are at school or away from home. With proper treatment and care, they can have a normal childhood and a full adult life.”
HCFI tips for Type 1 diabetes
·       Make a commitment to manage your diabetes.
·       Take your medications as recommended.
·       Learn all you can about type 1 diabetes.
·       Make healthy eating and physical activity part of your daily routine.
·       Keep a glucagon kit nearby in case of a low blood sugar emergency — and make sure your friends and loved ones know how to use it.
·       Schedule a yearly physical exam and regular eye exams. Your regular diabetes checkups aren't meant to replace yearly physicals or routine eye exams.
·       Keep your vaccinations up to date. High blood sugar can weaken your immune system. Get a flu shot every year.

Friday, March 30, 2018

The battle is still far from being won; the struggle must continue



Dr KK Aggarwal
Padma Shri Awardee

The Union Cabinet has cleared some amendments to the proposed National Medical Commission (NMC) Bill, which will now be debated in both Houses of the Parliament. Will they pass the amended Bill or will the Bill be passed by vote of voice remains to be seen. IMA and all doctor MPs should continue their efforts to get more amendments done before the Bill is passed.

·         Final MBBS Exam to be held as a common exam across the country as an exit test called the National Exit Test (NEXT): This is a victory of all. IMA had proposed last year. Now, the students would not have to appear in a separate exam after MBBS to get license to practice. NEXT would also serve as the screening test for doctors with foreign medical qualifications to practice in India. It will make more doctors available to practice. The next debate ….Who will conduct the exam?

·         Provision of Bridge course for AYUSH practitioners to practice limited modern medicine has been removed. But it has been left to the State Governments to take necessary measures for addressing and promoting primary health care in rural areas. This is a win for both Modern medicine and AYUSH systems of medicine. Ayush will now be able to continue research in their disciplines. If they had entered modern medicine, as had been earlier proposed, their very existence would have been at stake.

·         Fee (including all charges) regulation for 50% seats in private medical institutions and deemed universities. More details are needed, or the private institutions will increase the fee for 50% of seats in crores. A solution to this can be to increase number of government and district medical colleges.

·         Number of nominees from States and UTs in NMC increased marginally from 3 to 6. The NMC will comprise of 25 members of which at least 21 will be doctors. Not been able to increase the seats of registered medical practitioners is a major failure on our part.

·         Only 5 representatives from the registered doctors in states, as suggested to be 9 by the parliamentary committee, is too low a number. It seems that the government does not want IMA or professional representatives to be a part of it. It will be our collective failure if we are not being able to challenge it. Only one representative from each zone or all five from all India elections will make it interesting?

·         Monetary penalty for a medical college non-compliant with the norms has been replaced with a provision for different penalty options (warning, reasonable monetary penalty, reducing intake, stoppage of admission leading up to withdrawal of recognition etc). This needs to be studied in detail.

·         Stringent punishment for unqualified medical practitioners or quacks: The punishment for any unauthorized practice of medicine has been made severe by including a provision for imprisonment of up to one year along with a fine extending up to Rs. 5 lakhs. It’s good that it is ‘AND’ and not ‘OR’. Once convicted the imprisonment is a surety. We need to study the loop holes further.

Our struggle was not only against NMC…It was but one of our many demands.

The battle is still far from being won.

We were also fighting for suitable amendments in the Clinical Establishment Act (replacing police representative from DRA with a representative of the association; exempting single doctor establishment; doing away with NABH inspection, suggestion with respect to standard treatment guidelines to be provided by IMA and to define the change in the word ‘to stabilise’) and PCPNDT Act (graded punishments and non penal provisions for clerical errors).

A stringent central act against violence and capping of compensation (to be based on the lines of Drug and cosmetic rules in a clinical trial and not based on annual income of the patient) have been on the forefront of our agenda.

We also need to continue to voice our demands for increasing the health budgetary allocation to 5% of GDP; introduction of IMS on the lines of IAS and implementation of MCI Code of Ethics 8.6 to decide professional negligence and misconduct and MCI-IMA recommendations on police actions as recommended by the Hon’ble Supreme Court in any alleged criminal negligence.

Our demands of omission of penal provisions on doctors during practice, uniform pay scale for service doctors across the country and better service conditions for doctors and patients in government hospitals still remain unresolved.

Any government listens to pressure.

Events like IMA Dilli Chalo or IMA Mahapanchayat should be a part of our annual calendar of events and should become the extraordinary general body meeting of IMA and FOMA.

We should continue to fight for our rights as well as that of our patients till we achieve what we set out to do when we embarked on this journey. Even Rama, Krishna, Jesus had to fight for their principles.

What shape the NMC would ultimately take may well depend on how steadfast we are.

All resolutions must be adopted and fought for till they are achieved.

IMA will be taking further call on its plan of action on 2nd April after meeting with the Health Minister.